HSP90 Cancer Research Results

HSP90, HSP90: Click to Expand ⟱
Source: HalifaxProj(inhibit)
Type:
Heat shock protein 90 (Hsp90) is a molecular chaperone that plays a critical role in the proper folding, stabilization, and function of many proteins, including those involved in cell signaling, cell cycle regulation, and stress responses.
-Hsp90 interacts with a variety of client proteins that are often mutated or overexpressed in cancer. These include oncogenes (like HER2, BRAF, and AKT) and tumor suppressor proteins (like p53).
-Hsp90 is often overexpressed in cancer cells, which can help them survive under stressful conditions, such as those found in the tumor microenvironment. This overexpression is associated with poor prognosis in several types of cancer.
-HSPs, particularly HSP90, are known to stabilize many proteins that drive cancer progression (oncoproteins).


Scientific Papers found: Click to Expand⟱
3680- BBR,    Network pharmacology reveals that Berberine may function against Alzheimer’s disease via the AKT signaling pathway
- in-vivo, AD, NA
*Akt↑, *neuroP↑, *p‑ERK↑, *Aβ↓, *Inflam↓, *ROS↓, *BioAv↑, *BBB↑, *Half-Life↝, *memory↑, *cognitive↑, *HSP90↑, *APP↓, *mTOR↓, *P70S6K↓, *CD31↑, *VEGF↑, *N-cadherin↑, *Apoptosis↓,
3681- BBR,    The efficacy and mechanism of berberine in improving aging-related cognitive dysfunction: A study based on network pharmacology
- in-vivo, AD, NA
*memory↑, *cognitive↑, MAPK↑, *Akt↑, *PI3K↑, *TP53↑, *Jun↓, *HSP90↑, *neuroP↑, *Inflam↓, *antiOx↑, *p16↓, *ER Stress↓,
5674- BTZ,    Bortezomib-induced unfolded protein response increases oncolytic HSV-1 replication resulting in synergistic, anti-tumor effects
- in-vivo, GBM, NA - in-vivo, HNSCC, NA
ER Stress↑, GRP78/BiP↑, CHOP↑, PERK↑, IRE1↑, UPR↑, HSP70/HSPA5↑, HSP90↑, eff↑,
2429- PB,    Impact of butyrate on PKM2 and HSP90β expression in human colon tissues of different transformation stages: a comparison of gene and protein data
- in-vitro, Colon, NA
PKM2↓, *HSP90↑, HSP90∅,
1437- SFN,    Dietary Sulforaphane in Cancer Chemoprevention: The Role of Epigenetic Regulation and HDAC Inhibition
- Review, NA, NA
HDAC↓, HDAC1↓, HDAC2↓, HDAC3↓, HDAC8↓, eff↑, ac‑HSP90↑, DNMT1↓, DNMT3A↓, hTERT/TERT↓, NRF2↑, HO-1↑, NQO1↑, miR-155↓, miR-200c↑, SOX9↓, *toxicity↓,

Showing Research Papers: 1 to 5 of 5

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 5

Pathway results for Effect on Cancer / Diseased Cells:


Redox & Oxidative Stress

HO-1↑, 1,   NQO1↑, 1,   NRF2↑, 1,  

Core Metabolism/Glycolysis

PKM2↓, 1,  

Cell Death

hTERT/TERT↓, 1,   MAPK↑, 1,  

Kinase & Signal Transduction

SOX9↓, 1,  

Protein Folding & ER Stress

CHOP↑, 1,   ER Stress↑, 1,   GRP78/BiP↑, 1,   HSP70/HSPA5↑, 1,   HSP90↑, 1,   HSP90∅, 1,   ac‑HSP90↑, 1,   IRE1↑, 1,   PERK↑, 1,   UPR↑, 1,  

DNA Damage & Repair

DNMT1↓, 1,   DNMT3A↓, 1,  

Proliferation, Differentiation & Cell State

HDAC↓, 1,   HDAC1↓, 1,   HDAC2↓, 1,   HDAC3↓, 1,   HDAC8↓, 1,  

Migration

miR-155↓, 1,   miR-200c↑, 1,  

Drug Metabolism & Resistance

eff↑, 2,  

Clinical Biomarkers

hTERT/TERT↓, 1,  
Total Targets: 28

Pathway results for Effect on Normal Cells:


Redox & Oxidative Stress

antiOx↑, 1,   ROS↓, 1,  

Cell Death

Akt↑, 2,   Apoptosis↓, 1,  

Protein Folding & ER Stress

ER Stress↓, 1,   HSP90↑, 3,  

DNA Damage & Repair

p16↓, 1,   TP53↑, 1,  

Proliferation, Differentiation & Cell State

p‑ERK↑, 1,   Jun↓, 1,   mTOR↓, 1,   P70S6K↓, 1,   PI3K↑, 1,  

Migration

APP↓, 1,   CD31↑, 1,   N-cadherin↑, 1,  

Angiogenesis & Vasculature

VEGF↑, 1,  

Barriers & Transport

BBB↑, 1,  

Immune & Inflammatory Signaling

Inflam↓, 2,  

Protein Aggregation

Aβ↓, 1,  

Drug Metabolism & Resistance

BioAv↑, 1,   Half-Life↝, 1,  

Clinical Biomarkers

TP53↑, 1,  

Functional Outcomes

cognitive↑, 2,   memory↑, 2,   neuroP↑, 2,   toxicity↓, 1,  
Total Targets: 27

Scientific Paper Hit Count for: HSP90, HSP90
2 Berberine
1 Bortezomib
1 Phenylbutyrate
1 Sulforaphane (mainly Broccoli)
Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells
Filter Conditions: Pro/AntiFlg:%  IllCat:%  CanType:%  Cells:%  prod#:%  Target#:149  State#:%  Dir#:2
wNotes=0 sortOrder:rid,rpid

 

Home Page